Pharmaceuticals
Gilead gets Indian patent for hepatitis drug Sofosbuvir
10 May 2016
Non-profits like MSF and other consumer bodies say Indian authorities have bowed to US pressure in granting a patent to the hepatitis-C drug, which costs $1,000 per pill in the US
Ranbaxy ex-bosses to challenge Rs2,562-cr fine for hiding info from Daiichi
06 May 2016
In a majority ruling this week, a three-member arbitration panel in Singapore imposed a fine on the billionaire brothers earlier this week in a case filed by Daiichi Sankyo in 2013
Former Ranbaxy promoters ordered to pay Rs2,500 cr damages
06 May 2016
Daiichi filed an arbitration case in 2013 in Singapore, accusing the Indian promoters of concealment and misrepresentation of facts and seeking compensation for fines that it was forced to pay the US Department of Justice
